
CoFoE: Hajsel: Expansion of EMA's Powers Must Increase Transparency
Strasbourg, January 27 (TASR) – The approved measures must not only accelerate individual processes but also boost transparency in the conduct of clinical trials and approval of certificates needed to place medicines on the market, Slovak MEP Robert Hajsel has stated in reaction to the European Parliament’s approval of a